S&P 500   4,538.43
DOW   34,580.08
QQQ   383.13
S&P 500   4,538.43
DOW   34,580.08
QQQ   383.13
S&P 500   4,538.43
DOW   34,580.08
QQQ   383.13
S&P 500   4,538.43
DOW   34,580.08
QQQ   383.13

National Vision Stock Forecast, Price & News

-0.79 (-1.62%)
(As of 12/3/2021 12:00 AM ET)
Today's Range
50-Day Range
52-Week Range
2.02 million shs
Average Volume
681,295 shs
Market Capitalization
$3.97 billion
P/E Ratio
Dividend Yield
30 days | 90 days | 365 days | Advanced Chart
Receive EYE News and Ratings via Email

Sign-up to receive the latest news and ratings for National Vision and its competitors with MarketBeat's FREE daily newsletter.

National Vision logo

About National Vision

National Vision Holdings, Inc. engages in the retail of optical products. It operates through the following segments: Owned and Host, Legacy, and Corporate/Other. The Owned and Host segment consists of America's Best and Eyeglass World brands. The Legacy segment involves operations of, and supplies inventory and lab processing services. The Corporate/Other segment comprises of the results of operations of the other operating segments and corporate overhead support. The company was founded in 1990 and is headquartered in Duluth, GA.


National Vision (NASDAQ:EYE) Releases FY 2021 Earnings Guidance
November 24, 2021 |  americanbankingnews.com
National Vision (NASDAQ:EYE) & RxSight (NASDAQ:RXST) Financial Review
November 21, 2021 |  americanbankingnews.com
Analyzing RxSight (NASDAQ:RXST) and National Vision (NASDAQ:EYE)
November 18, 2021 |  americanbankingnews.com
See More Headlines

Industry, Sector and Symbol

Ophthalmic goods
Current Symbol
Year Founded

Sales & Book Value

Annual Sales
$1.71 billion
Cash Flow
$2.18 per share
Book Value
$11.19 per share


Net Income
$36.28 million
Pretax Margin




Free Float
Market Cap
$3.97 billion

Company Calendar

Last Earnings
Fiscal Year End
Next Earnings (Estimated)


Overall MarketRank

1.58 out of 5 stars

Medical Sector

1041st out of 1,390 stocks

Ophthalmic Goods Industry

5th out of 5 stocks

Analyst Opinion: 3.2Community Rank: 4.7Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

National Vision (NASDAQ:EYE) Frequently Asked Questions

Is National Vision a buy right now?

9 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for National Vision in the last twelve months. There are currently 1 sell rating, 3 hold ratings and 5 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" National Vision stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in EYE, but not buy additional shares or sell existing shares.
View analyst ratings for National Vision
or view top-rated stocks.

How has National Vision's stock been impacted by COVID-19 (Coronavirus)?

National Vision's stock was trading at $31.66 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, EYE stock has increased by 51.6% and is now trading at $47.99.
View which stocks have been most impacted by COVID-19

When is National Vision's next earnings date?

National Vision is scheduled to release its next quarterly earnings announcement on Wednesday, March 2nd 2022.
View our earnings forecast for National Vision

How were National Vision's earnings last quarter?

National Vision Holdings, Inc. (NASDAQ:EYE) issued its earnings results on Wednesday, November, 10th. The company reported $0.38 EPS for the quarter, beating analysts' consensus estimates of $0.25 by $0.13. National Vision had a net margin of 7.49% and a trailing twelve-month return on equity of 15.80%. During the same quarter last year, the company earned $0.52 EPS.
View National Vision's earnings history

How will National Vision's stock buyback program work?

National Vision announced that its board has authorized a stock repurchase plan on Monday, November 29th 2021, which permits the company to buyback $100,000,000.00 in outstanding shares, according to EventVestor. This buyback authorization permits the company to buy up to 2.5% of its shares through open market purchases. Shares buyback plans are typically a sign that the company's management believes its shares are undervalued.

What guidance has National Vision issued on next quarter's earnings?

National Vision updated its FY 2021 earnings guidance on Wednesday, December, 1st. The company provided earnings per share guidance of $1.280-$1.330 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $1.340. The company issued revenue guidance of $2.04 billion-$2.06 billion, compared to the consensus revenue estimate of $2.07 billion.

What price target have analysts set for EYE?

9 analysts have issued 1 year target prices for National Vision's shares. Their forecasts range from $50.00 to $70.00. On average, they expect National Vision's stock price to reach $59.75 in the next year. This suggests a possible upside of 24.5% from the stock's current price.
View analysts' price targets for National Vision
or view top-rated stocks among Wall Street analysts.

Who are National Vision's key executives?

National Vision's management team includes the following people:
  • L. Reade Fahs, Chief Executive Officer & Director (LinkedIn Profile)
  • Patrick R. Moore, Chief Financial Officer & Senior Vice President
  • Alex Louw, Chief Medical Officer & Senior Vice President
  • Ravi Acharya, Chief Technology Officer & Senior Vice President
  • Jared Brandman, Secretary, Senior Vice President & General Counsel (LinkedIn Profile)

What is L. Reade Fahs' approval rating as National Vision's CEO?

243 employees have rated National Vision CEO L. Reade Fahs on Glassdoor.com. L. Reade Fahs has an approval rating of 97% among National Vision's employees. This puts L. Reade Fahs in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

Who are some of National Vision's key competitors?

What other stocks do shareholders of National Vision own?

When did National Vision IPO?

(EYE) raised $300 million in an initial public offering (IPO) on Thursday, October 26th 2017. The company issued 15,800,000 shares at $18.00-$20.00 per share. BofA Merrill Lynch, Goldman Sachs, Citigroup, KKR, Morgan Stanley, Jefferies, UBS Investment Bank and Wells Fargo Securities acted as the underwriters for the IPO and Guggenheim Securities, Mizuho Securities and Macquarie Capital were co-managers.

What is National Vision's stock symbol?

National Vision trades on the NASDAQ under the ticker symbol "EYE."

Who are National Vision's major shareholders?

National Vision's stock is owned by many different retail and institutional investors. Top institutional shareholders include Alliancebernstein L.P. (5.32%), William Blair Investment Management LLC (4.68%), Wasatch Advisors Inc. (3.57%), Janus Henderson Group PLC (3.24%), Macquarie Group Ltd. (3.04%) and TimesSquare Capital Management LLC (2.24%). Company insiders that own National Vision stock include Jared Brandman, L Reade Fahs, Melissa Rasmussen, Mfn Partners, Lp and Patrick R Moore.
View institutional ownership trends for National Vision

Which institutional investors are selling National Vision stock?

EYE stock was sold by a variety of institutional investors in the last quarter, including Renaissance Technologies LLC, TimesSquare Capital Management LLC, Wasatch Advisors Inc., Eaton Vance Management, Voloridge Investment Management LLC, Natixis, Arrowstreet Capital Limited Partnership, and Eagle Asset Management Inc.. Company insiders that have sold National Vision company stock in the last year include Jared Brandman, L Reade Fahs, and Melissa Rasmussen.
View insider buying and selling activity for National Vision
or view top insider-selling stocks.

Which institutional investors are buying National Vision stock?

EYE stock was bought by a variety of institutional investors in the last quarter, including Alliancebernstein L.P., Wellington Management Group LLP, Bain Capital Public Equity Management II LLC, Allianz Asset Management GmbH, Goldman Sachs Group Inc., Dimensional Fund Advisors LP, AXA S.A., and Hodges Capital Management Inc..
View insider buying and selling activity for National Vision
or or view top insider-buying stocks.

How do I buy shares of National Vision?

Shares of EYE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is National Vision's stock price today?

One share of EYE stock can currently be purchased for approximately $47.99.

How much money does National Vision make?

National Vision has a market capitalization of $3.97 billion and generates $1.71 billion in revenue each year. The company earns $36.28 million in net income (profit) each year or $1.77 on an earnings per share basis.

How many employees does National Vision have?

National Vision employs 12,792 workers across the globe.

What is National Vision's official website?

The official website for National Vision is www.nationalvision.com.

Where are National Vision's headquarters?

National Vision is headquartered at 2435 COMMERCE AVENUE BLDG. 2200, DULUTH GA, 30096.

How can I contact National Vision?

National Vision's mailing address is 2435 COMMERCE AVENUE BLDG. 2200, DULUTH GA, 30096. The company can be reached via phone at (770) 822-3600 or via email at [email protected].

This page was last updated on 12/4/2021 by MarketBeat.com Staff


Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.